BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.64 USD -2.3% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
BioCryst Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

BCRX Price Targets Summary
BioCryst Pharmaceuticals Inc

Wall Street analysts forecast BCRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCRX is 14.74 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.

Lowest
Price Target
7.07 USD
7% Downside
Average
Price Target
14.74 USD
93% Upside
Highest
Price Target
31.5 USD
312% Upside

BCRX Last Price Targets
BioCryst Pharmaceuticals Inc

The latest public price target was made on Aug 6, 2024 by Gena Wang from Barclays , who expects BCRX stock to drop by 8% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Gena Wang
Barclays
7 USD
Downside 8%
3 months ago
Aug 6, 2024
BioCryst price target raised to $7 from $6 at Barclays
TheFly
Maury Raycroft
Jefferies
11 USD
Upside 44%
3 months ago
Aug 5, 2024
BioCryst Pharma (BCRX) PT Raised to $11 at Jefferies
StreetInsider
Gena Wang
Barclays
Price Target 7 USD
Upside/Downside 8%
View Source
Maury Raycroft
Jefferies
Price Target 11 USD
Upside/Downside 44%
View Source
BioCryst Pharmaceuticals Inc Competitors:
Price Targets
688373
Shanghai MicuRx Pharmaceutical Co Ltd
28% Upside
397030
AprilBio Co Ltd
59% Upside
RXRX
Recursion Pharmaceuticals Inc
41% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
14% Downside
688235
Beigene Ltd
14% Upside
300685
Amoy Diagnostics Co Ltd
2% Upside
688105
Nanjing Vazyme Biotech Co Ltd
16% Downside
VXRT
Vaxart Inc
590% Upside

Revenue
Forecast

Revenue Estimate
BioCryst Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for BioCryst Pharmaceuticals Inc's revenue is 27%. The projected CAGR for the next 3 years is 24%.

27%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
BioCryst Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
BioCryst Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCRX's stock price target?
Price Target
14.74 USD

According to Wall Street analysts, the average 1-year price target for BCRX is 14.74 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.

What is BioCryst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for BioCryst Pharmaceuticals Inc's revenue is 27%. The projected CAGR for the next 3 years is 24%.

Back to Top